StonvexLoading…
StonvexCore line items from MNSO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | ¥16.99B | ¥7.63B | ¥11.47B | ¥10.09B |
Operating Income | ¥3.32B | ¥1.55B | ¥2.22B | ¥882.03M |
Net Income | ¥2.64B | ¥1.26B | ¥1.78B | ¥639.74M |
EPS (Diluted) | ¥2.10 | ¥1.00 | ¥1.41 | ¥0.52 |
Total Assets | ¥18.12B | ¥14.49B | ¥13.45B | ¥11.28B |
Total Liabilities | ¥7.76B | ¥5.29B | ¥4.53B | ¥4.25B |
Cash & Equivalents | ¥6.33B | ¥6.42B | ¥6.49B | ¥5.35B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 1.26B | 1.26B | 1.23B |